a b s t r a c t
Hip implants containing cobalt-chromium (CoCr) have been used for over 80 years. In patients with metal-on-metal (MoM) hip implants, it has been suggested that wear debris particles may contribute to metal sensitization in some individuals, leading to adverse reactions. This article presents data from a study in which the popliteal lymph node assay (PLNA) was used to assess immune responses in mice treated with chromium-oxide (Cr 2 O 3 ) particles, metal salts (CoCl 2 , CrCl 3 , and NiCl 2 ) or Cr 2 O 3 particles with metal salts ("A preliminary evaluation of immune stimulation following exposure to metal particles and ions using the mouse popliteal lymph node assay" (B. 
Value of the data
These data represent the first use of the PLNA to test the immune response in mice treated with Cr 2 O 3 particles, and will be of value to researchers studying metal sensitization.
Histological parameters, including development of germinal centers and hyperplasia of lymphocytes in the cortex, are presented for mice treated with the test articles. These data will be of value in trying to understand the type of immune response observed following treatment with metal particles and ions and to researchers evaluating PLN histology following treatment with metals or other agents.
Flow cytometry was performed, evaluating the response of various types of immune cells,
These data will be of value in trying to fully characterize the type of immune response observed following treatment with metal particles and ions and to researchers evaluating changes in the percentage of immune cells in the PLN following treatment with metals or other agents.
PLN weight, flow cytometry and histology endpoints were all evaluated in the same treatment groups, allowing comparison across multiple endpoints to better assess the immune response. These data will be of value to researchers evaluating the immune response following treatment with metals or other agents. 
NA=tissue not available for analysis. c : À = no cortex present on sample, + =1-2 follicles, ++ =3-4 follicles, +++ =5-6 follicles, ++++ =7-8 follicles. d : + =all small lymphocytes, ++ =~5% immature lymphocytes, +++ =~10% immature lymphocytes. e : À = absent, + =minimal size, mature lymphocytes, ++ =medium size,~5% immature lymphocytes, +++ =large size, 10% immature lymphocytes, ++++ =extra-large size,~20% immature lymphocytes.cords filled. f : À = none observed, + =several, ++ =readily apparent, +++ =cords filled.
Data
This data in brief article contains data on the induced immune response in the popliteal lymph node (PLN) of mice treated with Cr 2 O 3 particles and/or metal salts from two experiments. From the first experiment, the following data are presented: compositional analysis of TiO 2 particles (Supplementary Fig. 1) ; evaluation of localized inflammation (Supplementary Table 1 ) and discoloration (Supplementary Table 2) in the footpad; mean footpad swelling ( Supplementary Fig. 2) ; mean change in body weight ( Supplementary Fig. 3 ); mean PLN weight (Fig. 1) ; histological evaluation of the PLN (Tables 1-4 Fig. 10, 11 ). From the second experiment, the following data are presented: evaluation of localized inflammation (Supplementary Table 3 ) and discoloration (Supplementary Table 4 ) in the footpad; mean footpad swelling ( Supplementary Fig. 12 ); mean change in body weight ( Supplementary Fig. 13 ); and mean PLN weight (Fig. 2) and WI (Fig. 3) . Please refer to [1] for related data and interpretations. 
Presence of plasma cells in medullary cords
NA=tissue not available for analysis. c : À = no cortex present on sample, + =1-2 follicles, ++ =3-4 follicles, +++ =5-6 follicles, ++++ =7-8 follicles. d : + =all small lymphocytes, ++ =~5% immature lymphocytes, +++ =~10% immature lymphocytes. e : À = absent, + =minimal size, mature lymphocytes, ++ =medium size,~5% immature lymphocytes, +++ =large size, 10% immature lymphocytes, ++++ =extra-large size,~20% immature lymphocytes. f : À = none observed, + =several, ++ =readily apparent, +++ =cords filled. g : À = absent, + =minimal foci. h : À = absent, + = minimal foci. i : = absent, + = minimal foci. Number of secondary follicles/germinal centers
Number of primary follicles 
Experimental design, materials and methods
The materials and methods have been described previously [1] . Briefly, the materials and methods were as follows:
Animals
Nulliparous, experimentally naïve, 6-8 week old female BALB/c mice (Charles River Laboratories) were housed in metal-free, disposable plastic cages. The mice were maintained on a 12-hour light/ dark cycle in a temperature-controlled environment, and were acclimatized for at least five days. Distilled water and rodent chow were provided ad libitum. All procedures complied with acceptable standards of animal welfare and humane care by the Institutional Animal Care and Use Committee (IACUC) of MB Research (Spinnerstown, PA) and Calvert Labs (Scott Township, PA).
Chemicals and reagents
The following reagents were purchased from the source listed in Table 5 .
Characterization of metallic particles
The morphology of the TiO 2 particles was determined using a Hitachi S5500 Ultra-high Resolution Scanning Electron Microscope at an accelerating voltage of 2.0 kV with secondary electron contrast at RJ Lee Group (Monroeville, PA). Composition of the TiO 2 particles was determined using a Bruker energy dispersive spectroscopy (EDS) detector at an accelerating voltage of 20 kV.
PLNA
Mice were anesthetized with isoflurane and injected subcutaneously with 50 μL of vehicle or test article into the right hind footpad. The dosing groups are presented in Table 6 .
All dilutions were prepared fresh daily and were stirred or vortexed until homogeneous. Dilutions were vortexed prior to dosing each mouse. Treatment doses were based on previous literature and dose-range finding studies [2] [3] [4] . See [1] for a detailed description of the rationale of dose formulations. 
Assessment of footpad swelling and general toxicity
The injection site of all animals was evaluated for signs of swelling or discoloration, and animals were evaluated for distress or signs of general toxicity approximately four hours after injection and once daily until sacrifice. Right hind footpad swelling was measured at 1, 2 and 4 days post injection in Experiment 1 and from Day 0 to 11 in Experiment 2 using a digital micrometer. Body weights were measured immediately prior to treatment on Day 0 and at sacrifice on Day 4, 7 or 11. Results for footpad swelling and percent of initial body weight are expressed as mean 7 standard error (SE).
PLN weight and cell proliferation
In Experiment 1, five hours before sacrifice on Day 4, mice were administered bromodeoxyuridine (BrdU) dissolved in PBS (3 mg per mouse; intraperitoneal). In Experiment 2, no BrdU was administered. Mice were euthanized with carbon dioxide inhalation, and the ipsilateral PLNs were excised from each mouse. PLNs were placed in PBS, adherent fatty tissue was removed, and PLNs were weighed. Results for ipsilateral PLN weight and weight index (Experiment 2 only) are expressed as mean 7standard error (SE).
For each individual PLN, a single cell suspension was made by gentle disaggregation with a disposable pestle, and cells were centrifuged, washed in PBS, and re-suspended in RPMI. In Experiment 1, the isolated LNCs were used for either determination of BrdU incorporation (fixed in 75% EtOH and stored up to one week at À 20°C) or for flow cytometric analyses (stored overnight at 2-8°C).
To determine BrdU incorporation in Experiment 1, cells were denatured with HCl Triton X Buffer (1 N HCl, 0.5% Triton X) and neutralized by washing with borate buffer (pH 8.5). Nuclei were washed with a staining buffer, incubated with BrdU-FITC (BD Biosciences, clone B44), washed again with staining buffer and resuspended in PBS containing RNase A (Fisher Scientific) and propidium iodide (PI, Sigma-Aldrich). Samples were incubated at room temperature for 30 min, and the percentage of BrdU þ nuclei (i.e., percentage of proliferating lymphocytes in the PLN) was determined with a BD FacScan s flow cytometer.
Flow cytometry
In Experiment 1, PLN cells were incubated with either Rat IgG (for B220, CD3, CD4, and CD8) or hamster/mouse IgG (for I-AD and CD69) for ten minutes to block non-specific binding. Approximately 5x10 5 cells were incubated for 30-45 min on ice with fluorescently-conjugated antibodies in the following pairs: (1) B220-FITC (BD Pharmingen, clone RA3-6B2) and CD3-PE (BD Pharmingen, clone 17A2); (2) CD4-PE (BD Pharmingen, clone RM4-5) and CD8-FITC (BD Pharmingen, clone 53-6.7); or (3) I-AD-FITC (Acris Antibodies, clone 34-5-3S) and CD69-PE (BD Pharmingen, clone H1.2F3). Cells were fixed with 70% ethanol and analyzed by flow cytometry on a BD FacScan s flow cytometer using 15 mW of power at 488 nm excitation wavelength. Data was acquired on BD CellQuest version 3.3 acquisition software, and CellQuest™ and FlowJo were used for data analysis.
Histology
For histological evaluation in Experiment 1 (n ¼2 per treatment group), PLNs were fixed in 10% neutral-buffered formalin and embedded in paraffin. Tissues were cut to 5 μm thickness and stained with hematoxylin and eosin (H&E). The pathologist evaluated the following parameters on a 0 to 4 scale: (1) number of primary follicles; (2) number of secondary follicles/germinal centers; (3) maturity of lymphocytes in the cortex; (4) lymphocyte hyperplasia in the paracortex; (5) plasma cells in the medullar cords; (6) necrosis; (7) acute inflammation (edema); and (8) acute inflammation (infiltration of polymorphonuclear cells). The vehicle control groups were used to establish the baseline scores, and the remaining groups were evaluated blinded as to treatment group.
